MENU
RXL
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

RXL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for RXL with price predictions
Nov 10, 2026

RXL's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for RXL turned positive on October 09, 2026. Looking at past instances where RXL's MACD turned positive, the stock continued to rise in 41 of 46 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on RXL as a result. In 79 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.

RXL moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RXL crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.

Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where RXL advanced for three days, in 275 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 227 of 255 cases where RXL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.

Bearish Trend Analysis

The 10-day RSI Indicator for RXL moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 26 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 56 of 69 cases where RXL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

RXL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Market Cap

The average market capitalization across the ProShares Ultra Health Care (RXL) ETF is 117.06B. The market cap for tickers in the group ranges from 9.59B to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is HSIC at 9.59B.

High and low price notable news

The average weekly price growth across all stocks in the ProShares Ultra Health Care (RXL) ETF was 12%. For the same ETF, the average monthly price growth was 34%, and the average quarterly price growth was 407%. ALGN experienced the highest price growth at 15%, while ILMN experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the ProShares Ultra Health Care (RXL) ETF was -26%. For the same stocks of the ETF, the average monthly volume growth was -18% and the average quarterly volume growth was -19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 44
Price Growth Rating: 24
SMR Rating: 58
Profit Risk Rating: 65
Seasonality Score: 24 (-100 ... +100)